Member Info for lumphammer

"Collectively, our results provide a new therapeutic rationale for the clinical development of combination treatments of chemotherapeutic DNA-targeted agents with ATR/CHK1 inhibitors based on SLFN11 status."

Excuse me, you 're not trying to ramp this share, are you?

First class post or second class

And the last 3 words were " pending successful progress ".
Don't hold your breath...

?

"These issuances ( the patents ) further build on our intellectual property position for sar737 " may 30 2017

Does the fact that sierra has the patent for sra737 in Europe and America until 2033 create an obstical as to the options for us, e.g. getting it back?

Up 11% today.
Are our gas prices fixed in Argentina like oil?

Just seen that Sareum are listed as members of biopartners

Biopartners on line virtual conference 8 - 12 June.
Any indication that sareum will take part?
If they do, can we then assume that currently they do not have a big name pharma lined up for licensing tyk2?

Great post. Made me chuckle. As an investor here and also a vegetable grower I can relate fully to what you said

And mathsprof

Thanks londonwolfie

That last 5M trade after hours on Friday. Does anyone know if I it was a buy or sell?

Aurora+flt for il-6 and tyk2/jak1 for the other cytokines ?

https://www.bbc.co.uk/news/uk-england-kent-52431390

I worked out roughly that they have sold about 16M over last few weeks/months.
Ouch!

Gilead have dropped 6% since that news leak

Was this share price really down 25% then made a recovery to break even at end of trading?
Jeez, how often does a share price fluctuate like that?

Well done, boilb
Guess that makes you the top sareum rep